HLA B 27 Disease Association
Also known as: Ankylosing Spondylitis, B27 Disease Association, Disease Association Testing
Use
Evaluate spondyloarthritis and other disorders associated with HLA-B27
Special Instructions
For further assistance in selecting the proper HLA test for patients, contact HLA customer service at 800-533-1037. This test should not be used as a screening procedure for ankylosing spondylitis due to potential false positives and the presence in normal individuals.
Limitations
Testing requires intact lymphocytes in whole blood specimens. Some samples may not be satisfactory even with precautions, necessitating fresh blood collection. The test does not cover rare HLA alleles that may cause false positives, and additional confirmatory or reflex tests may be needed. Not FDA cleared or approved.
Methodology
PCR-based
Biomarkers
LOINC Codes
- 26043-0
- 26043-0
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Adult tube
Minimum Volume
0.5 mL
Container
Lavender-top (EDTA) tube
Storage Instructions
Maintain blood specimen at room temperature.
Causes for Rejection
Hemolysis; clotted specimen; tube other than lavender-top (EDTA) tube